Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial

Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial

Show other versions (1)

<strong>Objective</strong> To compare the cost-utility of two exercise interventions relative to a control group for vasomotor menopausal symptoms. <strong>Design</strong> Economic evaluation taking a UK National Health Service and Personal Social Services perspective and...

Full description

Bibliographic Details
Main Authors:	Goranitis, I, Bellanca, L, Daley, A, Thomas, A, Stokes-Lampard, H, Roalfe, A, Jowett, S
Format:	Journal article
Published:	Public Library of Science 2017

Similar Items

Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial
by: Goranitis, I, et al.
Published: (2017)

Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial.
by: Ilias Goranitis, et al.
Published: (2017-01-01)

Women’s views about physical activity as a treatment for vasomotor menopausal symptoms: a qualitative study
by: Adèle Thomas, et al.
Published: (2020-09-01)

Menopause part I: Vasomotor symptoms (I)
by: Peng-Hui Wang, et al.
Published: (2025-03-01)

Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women.
by: Daley, A, et al.
Published: (2006)

Exercise participation, body mass index, and health-related quality of life in women of menopausal age.
by: Daley, A, et al.
Published: (2007)

Revolutionizing menopause management: Nonhormonal therapy for vasomotor symptoms
by: Shanzey Rai, et al.
Published: (2024-12-01)

Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
by: Savita Rani Singhal, et al.
Published: (2016-01-01)

Psychosomatic and vasomotor symptom changes during transition to menopause
by: Areti Augoulea, et al.
Published: (2019-06-01)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
by: Uml, et al.
Published: (2012-07-01)

Effectiveness of Hormone Replacement Therapy for Vasomotor Symptoms in Menopause
by: Anisa Fawad, et al.
Published: (2004-06-01)

Natural products and no-hormone therapy for the treatment of vasomotor symptoms affecting menopause women
by: Jaime Urdinola
Published: (2005-08-01)

Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN
by: Rebecca C. Thurston, et al.
Published: (2021-02-01)

The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms
by: F. N. Tuysuzoglu, et al.
Published: (2020-04-01)

Efficacy of Drospirenone-Containing Hormone Replacement Therapy to Reduce Vasomotor Symptoms of Menopause
by: Dana A. Brown, et al.
Published: (2013-10-01)

RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
by: Kalkan R, et al.
Published: (2020-08-01)

Effectiveness of acceptance and commitment therapy on sexual responsiveness, body self-esteem, and vasomotor symptoms in menopausal women
by: Mojtaba Aghili, et al.
Published: (2023-11-01)

“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
by: Ayesha Shaukat, et al.
Published: (2023-10-01)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
by: Melissa Conklin, et al.
Published: (2023-06-01)

Mind–body interventions for vasomotor symptoms in healthy menopausal women and breast cancer survivors. A systematic review
by: Evgenia Stefanopoulou, et al.
Published: (2017-07-01)

Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population‐Based Study
by: Sigrid Nilsson, et al.
Published: (2024-09-01)

Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
by: Khan SJ, et al.
Published: (2023-02-01)

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions
by: Deirdre R Pachman, et al.
Published: (2010-05-01)

Breakthroughs in women's health for treating vasomotor symptoms
by: Peng-Hui Wang, et al.
Published: (2024-11-01)

Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms
by: Fatemeh Abdi, et al.
Published: (2016-04-01)

Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
by: Taulant Muka, et al.
Published: (2016-01-01)

Insights into the genetics of menopausal vasomotor symptoms: genome-wide analyses of routinely-collected primary care health records
by: Katherine S. Ruth, et al.
Published: (2023-10-01)

Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women
by: Sena Sayan, et al.
Published: (2018-10-01)

Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause
by: Neil M. Schultz, et al.
Published: (2023-11-01)

Effects of insomnia and non-vasomotor menopausal symptoms on coronary heart disease risk: a mendelian randomization study
by: Ie-Bin Lian, et al.
Published: (2023-02-01)

Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial
by: Qi Yu, et al.
Published: (2024-05-01)

Efficacy and safety of non-hormonal agents for vasomotor symptoms of menopause: A prospective, double-blind, placebo-controlled study
by: Viktor E. Radzinsky, et al.
Published: (2023-07-01)

Vasomotor menopausal symptoms: is it just hot flashes? Alternative non-hormonal methods of treatment with proven effectiveness (literature review)
by: V. N. Kasyan, et al.
Published: (2021-01-01)

Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER’S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms
by: Paul C Langley
Published: (2023-03-01)

Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature Review
by: Supanimit Teekachunhatean, et al.
Published: (2015-01-01)

Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)
by: Xiangyan Ruan, et al.
Published: (2024-05-01)

The efficacy and safety of genistein in the treatment of vasomotor symptoms in postmenopausal women (research review)
by: I V Kuznetsova
Published: (2013-06-01)

Quality of the relationship and menopausal symptoms of menopausal women
by: Karolina Jarecka, et al.
Published: (2016-10-01)

The effect of aerobic exercise on sleep disorder in menopausal women: a systematic review and meta-analyses
by: Yan Jing, et al.
Published: (2024-12-01)

The effect of a session of moderate intensity aerobic exercise on inflammatory factors and flow-mediated dilation in pre-menopausal and post-menopausal women
by: Arsalan Damirchi, et al.
Published: (2024-04-01)